FDA Approved Products

4,491 products with lifecycle intelligence, competitive pressure scores, and patent timelines.

Active:Lifecycle: LOE ApproachingClear all
EMETE-CON
benzquinamide hydrochloride
LOE Approaching
Pfizer
RECTAL · SUPPOSITORY
1978
NDA
30/100
EMETE-CON
benzquinamide hydrochloride
LOE Approaching
Pfizer
INJECTION · INJECTABLE
1974
NDA
30/100
EMLA
lidocaine; prilocaine
LOE Approaching
Teva
TOPICAL · CREAM
1992
NDA
30/100
EMLA
lidocaine; prilocaine
LOE Approaching
AstraZeneca
TOPICAL · DISC
1998
NDA
30/100
EMSAM
selegiline
LOE Approaching
TRANSDERMAL · FILM, EXTENDED RELEASE
major depressive disorder (MDD) ()
2006
NDA
30/100
EMSAM
selegiline
LOE Approaching
TRANSDERMAL · SYSTEM
major depressive disorder (MDD) ()
2006
NDA
30/100
EMTRIVA
emtricitabine
LOE Approaching
Gilead Sciences
ORAL · CAPSULE
combination with other antiretroviral agents for the treatment of HIV-1 infection
2003
NDA
30/100
EMTRIVA
emtricitabine
LOE Approaching
Gilead Sciences
ORAL · SOLUTION
combination with other antiretroviral agents for the treatment of HIV-1 infection
2005
NDA
30/100
ENABLEX
darifenacin hydrobromide
LOE Approaching
AbbVie
ORAL · TABLET, EXTENDED RELEASE
overactive bladder with symptoms of urge urinary incontinenceurgency+1
2004
NDA
30/100
ENDOMETRIN
progesterone
LOE Approaching
Ferring Pharmaceuticals
VAGINAL · INSERT
2007
NDA
30/100
ENDURON
methyclothiazide
LOE Approaching
AbbVie
ORAL · TABLET
1960
NDA
30/100
ENDURONYL
deserpidine; methyclothiazide
LOE Approaching
Abbott
ORAL · TABLET
1961
NDA
30/100
ENDURONYL FORTE
deserpidine; methyclothiazide
LOE Approaching
Abbott
ORAL · TABLET
1961
NDA
30/100
ENJUVIA
estrogens, conjugated synthetic b
LOE Approaching
Aspen Surgical
ORAL · TABLET
the: Treatment of moderate to severe vasomotor symptoms associated with menopause
2004
NDA
30/100
ENJUVIA
estrogens, conjugated synthetic b
LOE Approaching
ORAL · TABLET
the: Treatment of moderate to severe vasomotor symptoms associated with menopause
2004
NDA
30/100
ENLON-PLUS
atropine sulfate; edrophonium chloride
LOE Approaching
INJECTION · INJECTABLE
older for: Atropine is an anticholinergic agent indicated in adultsolder for: Cycloplegia () Mydriasis () Penalization of the healthy eye in the treatment of amblyopia () 1
1991
NDA
30/100
ENLON-PLUS
atropine sulfate; edrophonium chloride
LOE Approaching
INJECTION · INJECTABLE
older for: Atropine is an anticholinergic agent indicated in adultsolder for: Cycloplegia () Mydriasis () Penalization of the healthy eye in the treatment of amblyopia () 1
1991
NDA
30/100
ENOVID
mestranol; norethynodrel
LOE Approaching
Pfizer
ORAL · TABLET
1961
NDA
30/100
ENOVID-E
mestranol; norethynodrel
LOE Approaching
Pfizer
ORAL-20 · TABLET
1961
NDA
30/100
ENOVID-E 21
mestranol; norethynodrel
LOE Approaching
Pfizer
ORAL-21 · TABLET
1961
NDA
30/100
ENTOCORT EC
budesonide
LOE Approaching
Design Pharmaceuticals
ORAL · CAPSULE, DELAYED RELEASE
mild to moderate active Crohn's disease involving the ileum and/or the ascending colon in patients 8 years of ageolder+2
2001
NDA
30/100
EOVIST
gadoxetate disodium
LOE Approaching
Bayer
INTRAVENOUS · SOLUTION
2008
NDA
30/100
EPI E Z PEN JR
epinephrine
LOE Approaching
Viatris (2)
INTRAMUSCULAR · INJECTABLE
the emergency treatment of allergic reactions (Type I) including anaphylaxis
1987
NDA
30/100
EPIPEN
epinephrine
LOE Approaching
Viatris (2)
INTRAMUSCULAR, SUBCUTANEOUS · INJECTABLE
the emergency treatment of allergic reactions (Type I) including anaphylaxis
1987
NDA
30/100
← PreviousPage 58 of 188Next →